Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Emulex Says Fred Cox Not To Seek Re-Election To Board - Quick Facts

RELATED NEWS
Trade ELX now with 
6/15/2012 8:36 AM ET

Emulex Corp. (ELX: Quote) said that Fred Cox, Emulex co-founder and current Chairman Emeritus, will not seek re-election to the Board at this year's Annual General Meeting of Shareholders.

Fred Cox served as CEO of Emulex for more than 12 years, from the company's inception until he retired from active management in October 1990. Cox then served as Emulex's non-executive chairman for an additional eight years. His planned retirement from the Board in November will mark 34 years of continuous service to the company.

Click here to receive FREE breaking news email alerts for Emulex Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
After moving notably lower over the course of the previous session, stocks are likely to see further downside in early trading on Thursday. The major index futures are currently pointing to a sharply lower open for the markets, with the Dow futures down by 123 points. The U.K. economy avoided recession in the first quarter as initially estimated, but the detailed breakdown of gross domestic product highlighted major contribution coming only from built up stocks of companies. Gross domestic product grew 0.3 percent sequentially in the first quarter, offsetting the last quarter's 0.3 percent fall, second estimates from the Office for National Statistics showed. An indicator of Eurozone's private sector activity improved more than expected in May, renewing hopes that the economy is inching towards a recovery. Nonetheless, the indicator remained in negative territory, signaling sharp deterioration in overall business activity. The composite output index rose to a three-month high of 47.7 in May from 46.9 in April.
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.